HCPCS code Q5126 — Inj alymsys 10 mg. Status: Active. Effective Jan 1, 2023. Source: CMS HCPCS Level II.

Q5126

Active

Inj alymsys 10 mg

Injection, bevacizumab-maly, biosimilar, (alymsys), 10 mg

Category: Temporary
Section: Q-codes: Temporary Codes
Effective: Jan 1, 2023
Code type: alphanumeric
OPPS Status: K — Non-pass-through drugs and biologicals
OPPS APC: 9048

MUE — Medically Unlikely Edits

Maximum units of Q5126 Medicare will pay for one beneficiary on one date of service. Claims exceeding the MUE are denied or returned for review.

Service Type Max Units / Day
Outpatient Hospital 230
Practitioner Services 230

Source: CMS Medicare NCCI Medically Unlikely Edits

NDC Crosswalk

National Drug Codes (NDCs) mapped to this HCPCS code.

NDC Drug Name
70121-1754-01 Alymsys
70121-1755-01 Alymsys

Change History

Quarterly changes published by CMS. Revisions may affect the code description, coverage, or rate — review each quarter's changes before submitting claims.

  • New Code 2023-Q1
    Inj alymsys 10 mg